AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Biosimulation Market 2019-2023 | Evolving Opportunities with Certara L.P. and Dassault Systèmes SE | Technavio

November 22, 2019 GMT
Global Biosimulation Market 2019-2023 | Evolving Opportunities with Certara L.P. and Dassault Systèmes SE | Technavio
Global Biosimulation Market 2019-2023 | Evolving Opportunities with Certara L.P. and Dassault Systèmes SE | Technavio

LONDON--(BUSINESS WIRE)--Nov 22, 2019--

Technavio has been monitoring the global biosimulation market since 2014 and the market is poised to grow by USD 1.42 billion during 2019-2023 at a CAGR of over 14% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191122005313/en/

Technavio has announced its latest market research report titled global biosimulation market 2019-2023 (Graphic: Business Wire)

Read the 117-page research report with TOC on “Biosimulation Market Analysis Report by End-users (Pharmaceutical and biotechnology companies, Contract research organizations, and Others), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023”.

The market is driven by the increase in mergers and acquisition (M&A) activities. In addition, the use of mathematical modeling and simulation to improve generic drugs is anticipated to further boost the growth of the biosimulation market.

Vendors in the market are focusing on accessing new geographies and broadening their portfolio by adopting M&A as one of the main growth strategies. They are focusing on consolidating their core business in the existing as well as new markets through this strategy. The adoption of this strategy further improves their overall position in the market by helping them achieve operational expertise. Thus, the increase in M&A activities is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing

Major Five Biosimulation Market Companies:

Certara L.P.

Certara L.P. is headquartered in the US and operates the business under the unified business segment. The company offers Simcyp PBPK Modeling and Simulation as a population-based simulator.

Dassault Systèmes SE

Dassault Systèmes SE is headquartered in France and offers products through the following business units: Software revenue and Services revenue. The company offers BIOVIA Draw as a software that facilitates collaborative viewing and archiving of scientific information.

Physiomics Plc

Physiomics Plc is headquartered in the UK and operates under the unified business segment. The company offers Pharmacokinetic (PK) & Pharmacodynamic (PD) modeling platform for its customers.

Schrödinger LLC

Schrödinger LLC is headquartered in the US and offers products through the unified business segment. The company offers BioLuminate as an advanced user interface software.

Simulations Plus Inc.

Simulations Plus Inc. is headquartered in the US and offers products through the following business segments: Simulations Plus Inc., Cognigen Corporation, and DILIsym Services Inc. The company offers GastroPlus as a simulation software package.

Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform

Biosimulation End-Users Outlook (Revenue, USD Million, 2019 - 2023)

Biosimulation Regional Outlook (Revenue, USD Million, 2019 - 2023)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Careare:

Biotechnology Reagents Market – Global Biotechnology Reagents Market by technology (chromatography, in-vitro diagnostics, polymerase chain reaction, cell culture, and others), and geography (the Americas, APAC, and EMEA).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191122005313/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH TECHNOLOGY OTHER SCIENCE SOFTWARE SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 11/22/2019 01:00 PM/DISC: 11/22/2019 01:00 PM

http://www.businesswire.com/news/home/20191122005313/en